Nichi-Iko Pharmaceutical Co., Ltd. announced consolidated earnings results for the six months ended September 30, 2018. For the period, the company reported revenue of JPY 82,346 million as compared to JPY 83,060 million for the same period last year. Operating income was JPY 4,720 million as compare to JPY 2,695 million for the same period last year. Profit was JPY 4,620 as compared to JPY 2,446 for the same period last year. Basic earnings per share were JPY 80.93 as compared to JPY 43.45 for the same period last year. Diluted earnings per share were JPY 79.79 as compared to JPY 43.38 for the same period last year.

For the year, the company expects net sales of JPY 170,000 million, operating income of JPY 9,500 million, net income attributable to shareholders of the parent company of JPY 7,000 million and net income per share of JPY 118.99.